StockData
VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31

VITASPRING BIOMEDICAL CO. LTD.

Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 17, 2026
$0.03+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$6.58M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Vitaspring Biomedical has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Vitaspring Biomedical filed with the SEC